Bank of Montreal
SQZ

Bank of Montreal’s SQZ Biotechnologies Company SQZ Stock Holding History

Bank of Montreal’s Portfolio SQZ Stock Details SQZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-183
Closed -$2K – 5240
2021
Q1 		$2K Sell
183
-517
-74% -$10.5K ﹤0.01% 4941
2020
Q4 		$19K Buy
+700
New +$17.9K ﹤0.01% 4448

Other funds holding SQZ

Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LM
Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of Montreal's SQZ Position: Q2 2021 in Review

Bank of Montreal sold out of SQZ Biotechnologies Company (SQZ) in Q2 2021, closing a stake of 183 shares — an estimated $2K sold.

Bank of Montreal first reported a position in SQZ in Q4 2020 and held it in 2 quarters. The position peaked at $19K in Q4 2020. 49 funds tracked by Wall St. Rank hold SQZ as of Q2 2021.

  • Bank of Montreal reported no remaining SQZ Biotechnologies Company position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 183 SQZ Biotechnologies Company shares in Q2 2021, an estimated $2K.
  • Bank of Montreal first reported a position in SQZ Biotechnologies Company in Q4 2020 and held it in 2 quarters.
  • Bank of Montreal's SQZ Biotechnologies Company position peaked at $19K in Q4 2020.
  • 49 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.